The global Intravenous Solutions Market was valued at around US$ 10.9 Bn in 2021. With a projected CAGR of 10.8% for the next ten years, the market is likely to reach a valuation of nearly US$ 33.6 Bn by the end of 2032. The demand for Intravenous solutions is anticipated to increase in the coming years due to the sedentary lifestyle of about 39% of the world population, particularly among the aging population as a result of chronic conditions like cancer, heart disease, stroke, diabetes, and arthritis.
Companies
- Fresenius Kabi
- Sino-Swed Pharmaceutical Corp., Ltd
- Hospira
- Amanta Healthcare
- Otsuka Pharmaceutical Co., Ltd
- Sichuan Kelun Pharmaceutical Co., Ltd
- Terumo Corporation
- Baxter
- B. Braun Melsungen AG
- Claris Lifesciences Ltd
- Kyowa Hakko Bio Co., Ltd
- Grifols
- Liqvor Pharmaceuticals
Get Free Sample Copy Of This Report To Understand The Structure Of The Complete Report@ https://www.persistencemarketresearch.com/samples/33231
Sales Analysis of Intravenous Solutions Market from 2017 to 2021 Vs Market Outlook for 2022 to 2032
The global market for the Intravenous Solutions Market expanded at a CAGR of 10% during 2017-2021. As per the Faculty of Health Centre for Rural Health (Australia), more than 75% of patients admitted to hospitals are receiving some type of IV therapy. The United States will continue to be the largest consumer of Intravenous Solutions throughout the analysis period accounting for over US$ 8.8 Bn absolute dollar opportunity in the coming 10-year period.
Region-wise Insights
Why Intravenous Solutions Market in Asia Pacific is Projected to Offer Significant Oppotrunity?
The market in Asia Pacific is projected to register the fastest growth with a projected CAGR of over 11%. China and India account for more than 3.5 Mn preterm births annually, or 24% of all preterm births worldwide. Premature babies are more likely to experience poor growth and illnesses. Therefore, early parenteral nutrition is essential for preterm infants and must provide enough energy and amino acids. This is anticipated to drive the Asia Pacific intravenous (IV) solutions market in the years to come.
To get extensive insights on key trends, request for customization here@ https://www.persistencemarketresearch.com/request-customization/33231
Key Segments Covered in Intravenous Solutions Market Survey
By Type:
- Total Parenteral Nutrition (TPN)
- Peripheral Parenteral Nutrition (PPN)
By Nutrients:
- Carbohydrates
- Single Dose Amino Acid Solution
- Vitamins & Minerals (Salt and Electrolyte)
- Parenteral Lipid Emulsion
- Other Nutrients
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/33226
Related Reports:
Veterinary Teleradiology Market
Dental Radiology Equipment Market
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]